Told diet and exercise for years: who follows up and how often?

For 10 years, the advice has not changed. Eat less, move more and come back next year. You did the first two more often than anyone gave you credit for. You came back too. The weight held or crept upward, while the annual panel kept returning a glucose the report called normal. Somewhere along the way, you stopped raising it. If you were told diet and exercise for years and have privately decided the problem is your discipline, this piece is written for you. The person described here is a composite drawn from that situation. No real patient's story is told.

This piece answers the practical question people in that position ask before they pay for anything new. How fast do I hear from a clinician and how often after that? The short answer is specific. GoodLife Health measures fasting insulin before glucose turns abnormal. A clinician reads it with you in four cardiometabolic lab panels a year, one every 90 days. Between panels, you can message the care team whenever something comes up. We do not promise a response time measured in minutes or hours. The rest of this piece explains what happens first, what repeats and what we do promise.

10 years of the same visit

The visit usually follows a script. You get an eight-minute appointment and a basic panel. The clinician looks at the glucose and the cholesterol and then says the sentence you could recite yourself: “Keep working on diet and exercise.” Nobody in the room is being unkind. The appointment is built for one complaint and a refill. There is no time inside it to ask why years of effort have not moved anything. The panel it orders does not include the marker that would open that question.

Over a decade, that visit repeats eight or nine times. Each time, the glucose is called normal and the plan stays where it was. The visit has no way to notice that the same advice has failed the same person for years. It does not hold the record of what was tried, what changed and what did not.

What happens to a person inside that loop is quieter than anger. You start editing what you say in the exam room. You stop mentioning the slump after lunch, since you already know the answer. You try the next plan from a podcast or a colleague. When it stalls, you file the result under your own failure. By year eight or nine, the conclusion feels settled. The advice is sound, so the fault must be yours.

That conclusion deserves a fair hearing. In some years, you may have eaten worse than you meant to. You may have let whole seasons pass without exercise. Most people have. None of that answers the clinical question of what your metabolism was doing with the food you did eat. That question needs a number the visit never ordered.

Being dismissed this way also changes how a person shops for help. You may now distrust anything that promises a fast fix. That instinct is sound. The question in this piece, how fast and how often, tests something more useful than a promise. It shows whether a new arrangement would follow your numbers or repeat the yearly script at a higher price.

What a normal glucose leaves out

A basic panel reports fasting glucose. Many add A1C. Both describe the sugar in your blood. They are the markers a routine visit uses to look for diabetes. When they sit inside their ranges, the visit moves on.

Fasting insulin is a separate marker. It is the one your decade of panels never included. GoodLife Health measures fasting insulin before glucose turns abnormal and reads it beside A1C, which is the reason to draw it at all. A glucose inside its range on a given morning describes that morning. It cannot show whether insulin resistance was building underneath, because nobody drew the marker that would show it.

The word “normal” on a report means your value fell inside a range drawn from a large population. You are one person. A range describes where most people land on a single day. It says nothing about the direction your own numbers have been moving, since no one has been following the direction.

That matters for the verdict you have reached about yourself. A decade of normal glucose readings tells you the glucose was normal on those mornings. It does not tell you why the advice stopped working. It does not tell you the fault was yours either.

If you have a GP, you already have someone who can order fasting insulin. Ask at your next visit. Some will add it. If yours does, you will have learned something real for the price of a request. What a single added marker leaves to chance is the follow-through. Someone has to read the next result 90 days later, compare it with the first and change the plan if the number has not moved. The annual visit was not built to do that. A GP with a full schedule may not have the room.

How fast you hear from a clinician and how often after

The fast part has a fixed order. The order works in your favor.

Before anything is charged

The first contact is the eligibility check. It is a short set of questions about whether the membership could fit you at all. The intake follows, where you give your history in your own words. Include the decade of advice, the plans you tried and any panels you still have. Checkout comes next. At checkout, $598 is held on your card to cover the first two months. It is a hold and not a charge. A clinician then reviews what you sent. If the clinician cannot accept you into care, the hold is released and you are never charged. If the clinician accepts you, the first two months are charged and are non-refundable.

Not everyone is accepted. The first clinical judgment about you happens before the first payment. It is made by a clinician reading your story.

How long does that review take? We do not publish a fixed time. We would rather say so than print a number we cannot stand behind. What we can tell you is the sequence. A person with your history is read by a clinician before any money moves.

The first panel

Once you are accepted, the first of your four cardiometabolic lab panels for the year is ordered. For someone in your situation, it may be the first time fasting insulin has appeared on the same page as A1C and glucose. Every result comes to you as well as to the clinician. You see the numbers that were missing for 10 years, with dates beside them.

The first conversation starts from those numbers. It can happen by video visit or by message. It covers what the results show, what they cannot show yet and what the plan is until the next draw. That plan may include a medication or may not. The guide to what a direct primary care visit actually looks like walks through how such a visit runs.

Every 90 days

The how-often half of the answer is the clearer one. The Biomarker Audit repeats every 90 days. That makes four panels a year, each one read against the last. For insulin resistance, that cadence matters more than any single appointment. Fasting insulin followed over two or three quarters shows whether the plan is doing anything. A single value cannot.

Compare it with the rhythm you know. An annual visit gives you one reading a year. A decade of annual visits gives you 10 readings, each judged alone and each called normal. Four panels a year give you a line with a direction. The clinician who reads that line stays with you, so nobody starts from zero.

Between visits

Between panels, you message the care team whenever something changes. You might write about a side effect, a result that confuses you or a plan that no longer fits your week. Messaging is asynchronous. You write when it suits you. The care team replies between visits.

We do not promise a response time, in this piece or anywhere else. What we do promise is the structure around the messages. The care team answers between visits. The panels come every 90 days. The clinician who reads them stays.

For a reader who has spent years not bringing things up, the larger change may be permission. You can raise the slump after lunch in a message on a Tuesday. You do not have to save it for next year's appointment with room for one complaint.

What it costs and what it does not do

The membership is $299 a month. The $598 hold described above covers the first two months. It is released and never charged if a clinician cannot accept you. Once you are accepted, those two months are charged and are non-refundable. From month three, the membership is month to month. A full year comes to $3,588.

The fee covers clinicians licensed in all fifty states, four cardiometabolic lab panels a year, every result in your hands, video visits and asynchronous messaging with the care team. It is the same whatever medication is indicated and whatever the dose. The guide to what a direct primary care membership includes sets out where the wider model draws its lines.

Medication is separate. GoodLife Health prescribes branded, FDA-approved medication only. When a clinician judges a medication indicated, it is prescribed to the pharmacy you choose at that pharmacy's own price. GoodLife Health sets nothing, sees nothing and takes nothing on medication. That pharmacy's own return and refund policy applies to anything it bills. Whether your insurance covers a medication is between you, your plan and the pharmacy.

If a GLP-1 such as Wegovy or Zepbound becomes part of a plan, the manufacturers now publish their own self-pay prices with dates attached. In September 2026, NovoCare listed Wegovy pens at $199 a month for the first two fills and $349 a month after. The $199 price is an introductory offer for new patients through December 2026. NovoCare also listed the Wegovy pill from $149 a month at lower doses. LillyDirect listed Zepbound vials at $299 to $449 a month depending on dose.

The membership does not replace insurance. Keep your plan for the hospital and for emergencies. The membership pairs with that coverage and replaces the primary-care relationship. Its scope is precision direct primary care for cardiometabolic optimization, so it does not cover every need a general practice handles. It cannot promise weight loss, remission or a cure. It does not try.

What makes it different is the order of the work and the absence of a stake in the prescription. It tests first, treats second and sells neither the drug nor the dose. Under Medication-Neutral Pricing, nobody on the team earns more when a dose rises or a drug starts. For a reader handed advice without measurement for a decade, that order is the point. GoodLife Health sits between the $20,000-a-year concierge practice and the $99-a-month compounded app. It says so plainly.

What to do this week, whether you join or not

Some of what would help you this week takes only a few minutes.

First, gather every panel you can find from the last decade. Write each date beside its fasting glucose and any A1C that was drawn. Seen together, the numbers become a record you can read.

Second, ask your current clinician to add fasting insulin to your next draw. Ask who will read the result and when you will hear about it. The answer tells you how fast and how often that practice will follow up, which is the question you are asking us.

Third, write a short and honest list of what you have actually done. Include the plans, the months they lasted and what happened. Bring it to whoever reads your numbers next. It shows a clinician the effort the yearly visit had no place to record. It may show you too.

We should be plain about what we do not know. We cannot tell from here whether you have insulin resistance. Neither can you until fasting insulin is drawn and read. We cannot promise what the panels will show or what a plan will achieve. We can promise the order. The marker is drawn before the advice is repeated. The next panel follows 90 days later.

Who this is not for

This membership is not for someone who wants a prescription this week without a panel. It tests first. A person who wants to skip the testing will find it slow.

It is not for someone who needs a guaranteed reply within the hour. We do not promise a response time. If that guarantee matters most, choose a service that offers one and read its terms closely.

It is not for someone whose first concern is the lowest monthly figure. A $99-a-month compounded app will cost less each month. This membership will not argue the point. Its case rests on a different arrangement. A clinician measures before prescribing. The company takes nothing on what is prescribed.

It does not replace insurance or emergency care. It serves residents of the fifty states and is not for anyone living outside the United States.

For the reader this piece was written for, here is the offer in full. GoodLife Health costs $299 a month. At sign-up, $598 is held for the first two months and is charged only once a clinician accepts you. If you are not accepted, the hold is released and you are never charged. Once you are accepted, the first two months are charged and are non-refundable. After that, the membership runs month to month. It buys a quarterly panel that includes fasting insulin, a clinician who stays and medication prescribed to your own pharmacy at that pharmacy's price, with nothing taken on it. It returns the workup a decade of visits never produced, your markers followed every 90 days and an end to the eight-minute visit. It is different because it tests first, treats second and sells neither the drug nor the dose. If you have spent 10 years concluding the fault is yours, the next useful number is one panel away. Every month of waiting is another month of the same advice resting on the same missing marker.

Related Reading

• What a Direct Primary Care Visit Actually Looks Like (2026)
• What Does a Direct Primary Care Membership Include in 2026

References

1. NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
2. Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings